XTL BIOPHARMACEUTICALS LTD. Royalty Expense
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Royalty Expense of $350.00 thousand for the 1-month period ending 2010-08-03, per its 20-F filed 2020-03-12.
Discontinued › Operating Expenses
ifrs-full:RoyaltyExpense · last filed 2023-03-22
- 2010-08-03: Royalty Expense 0 month $350.00K; Royalty Expense 1 month $350.00K.
| Period end | Royalty Expense 0 month | Royalty Expense 1 month |
|---|---|---|
| 2010-08-03 | $350.00K 20-F · filed 2023-03-22 | $350.00K 20-F · filed 2020-03-12 |